Wollenberg, A., Cork, M., Flohr, C., Bewley, A., Blauvelt, A., Hong, C.- ho, Imafuku, S., Schuttelaar, M.L., Simpson, E., Soong, W., Amoudruz, P., Wendicke Lophaven, K. , Kurbasic, A., Soldbro, L., Strange Vest, N. and Paller, A. 2023. Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s140. DOI:https://doi.org/10.25251/skin.7.supp.140.